Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Teva Pharmaceutical Industries Insider Sold Shares Worth $14,356,802, According to a Recent SEC Filing

Teva Pharmaceutical Industries Insider Sold Shares Worth $14,356,802, According to a Recent SEC Filing

MT newswireMT newswire2026/09/22 20:28
04:28 PM EDT, 09/22/2026 (MT Newswires) -- Roberto Mignone, Director, on September 19, 2026, sold 367,600 shares in Teva Pharmaceutical Industries (TEVA) for $14,356,802. Following the Form 4 filing with the SEC, Mignone has control over a total of 119,807 ordinary shares of the company, with 119,807 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/818686/000119312526397959/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Intel (INTC.US) CEO Pat Gelsinger praises China's cutting-edge AI models and firmly supports open source for efficiency improvement

On Monday, Chen Liwu stated that the single-token cost for China’s advanced artificial intelligence (AI) models is lower, and these models have seen “very rapid” adoption. He also added: “I am a firm supporter of open source. This is the best way to drive efficiency improvements.”

智通财经•2026/10/12 13:26